E-LIB Suche - Ergebnisse für: Fasth, Andreas E R

1

Impact of psoriasis disease activity and other risk factors..:

Dehlin, Mats ; Fasth, Andreas E R ; Reinhardt, Maximilian.
Rheumatology Advances in Practice. 5 (2021) 1 - p. , 2021

Link: https://doi.org/10.1093/..

2

Secukinumab efficacy on resolution of enthesitis in psoriat..:

Coates, Laura C. ; Wallman, Johan K. ; McGonagle, Dennis...
Arthritis Research & Therapy. 21 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

3

CD4+ and CD8+ CD28null T Cells Are Cytotoxic to Autologous ..:

Pandya, Jayesh M. ; Venalis, Paulius ; Al‐Khalili, Lubna...
Arthritis & Rheumatology. 68 (2016) 8 - p. 2016-2026 , 2016

Link: https://doi.org/10.1002/..

4

Reply:

Malmström, Vivianne ; Pandya, Jayesh M. ; Lundberg, Ingrid E..
Arthritis & Rheumatology. 69 (2016) 1 - p. 243-244 , 2016

Link: https://doi.org/10.1002/..

5

Balance between activating NKG2D, DNAM‐1, NKp44 and NKp46 a..:

Nielsen, Natasja ; Pascal, Veronique ; Fasth, Andreas E. R....
Immunology. 142 (2014) 4 - p. 581-593 , 2014

Link: https://doi.org/10.1111/..

6

Activating NK‐cell receptors co‐stimulate CD4+CD28− T cells..:

Fasth, Andreas E. R. ; Björkström, Niklas K. ; Anthoni, Minna..
European Journal of Immunology. 40 (2010) 2 - p. 378-387 , 2010

Link: https://doi.org/10.1002/..

7

Expanded T cell receptor Vβ–restricted T cells from patient..:

Pandya, Jayesh M. ; Fasth, Andreas E. R. ; Zong, Mei...
Arthritis & Rheumatism. 62 (2010) 11 - p. 3457-3466 , 2010

Link: https://doi.org/10.1002/..

8

High mobility group box chromosomal protein 1 acts as a pro..:

Sundberg, Erik ; Fasth, Andreas E.R. ; Palmblad, Karin..
Immunobiology. 214 (2009) 4 - p. 303-309 , 2009

Link: https://doi.org/10.1016/..

9

Secukinumab efficacy on resolution of enthesitis in psoriat..:

Coates, Laura C ; Wallman, Johan K ; McGonagle, Dennis...
https://eprints.gla.ac.uk/207264/7/207264.pdf. , 2019

Link: https://eprints.gla.ac.u..

10

Secukinumab efficacy on resolution of enthesitis in psoriat..:

Coates, Laura C ; Wallman, Johan K ; McGonagle, Dennis...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/14338. , 2019

Link: https://opus4.kobv.de/op..

11

Secukinumab efficacy on resolution of enthesitis in psoriat..:

Laura C. Coates ; Johan K. Wallman ; Dennis McGonagle...
https://doi.org/10.1186/s13075-019-2055-z. , 2019

Link: https://doi.org/10.1186/..

12

254 Impact of secukinumab treatment on psoriatic arthritis ..:

McInnes, Iain B ; Wallman, Johan K ; Schett, Georg...
Rheumatology. 58 (2019) Supplement_3 - p. , 2019

Link: https://doi.org/10.1093/..

13

Secukinumab treatment in new‐onset psoriasis: aiming to und..:

Iversen, L. ; Eidsmo, L. ; Austad, J....
Journal of the European Academy of Dermatology and Venereology. 32 (2018) 11 - p. 1930-1939 , 2018

Link: https://doi.org/10.1111/..

14

CD28nullCD4+ T Cells – Characterization of an Effector Memo..:

Fasth, A. E. R. ; Cao, D. ; Van Vollenhoven, R...
Scandinavian Journal of Immunology. 60 (2004) 1-2 - p. 199-208 , 2004

Link: https://doi.org/10.1111/..

15

Can Lava Flow Like Water? Assessing Applications of Critica..:

Dietterich, H. R. ; Grant, G. E. ; Fasth, B...
Journal of Geophysical Research: Earth Surface. 127 (2022) 9 - p. , 2022

Link: https://doi.org/10.1029/..